Skip to content

The effect of transcutaneous vagus nerve stimulation on postoperative gastrointestinal dysfunction in patients with gynecological abdominal and pelvic tumors: A prospective, single center, randomized, double-blind, controlled clinical study

The effect of transcutaneous vagus nerve stimulation on postoperative gastrointestinal dysfunction in patients with gynecological abdominal and pelvic tumors: A prospective, single center, randomized, double-blind, controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104412
Enrollment
Unknown
Registered
2025-06-17
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative gastrointestinal dysfunction

Interventions

Control group:Transcutaneous vagus nerve sham stimulation
Experimental group:Transcutaneous vagus nerve stimulation

Sponsors

Huzhou Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Selective gynecological surgery for abdominal and pelvic tumors under general anesthesia, with pathological characteristics of tumors; 3.The American Society of Anesthesiologists classifies as Grade I to III; 4.Voluntary signing of informed consent form.

Exclusion criteria

Exclusion criteria: 1.Gastrointestinal motility disorders; 2.Previous abdominal surgery; 3.Having neurological and psychiatric disorders, as well as a history of neurological or psychiatric disorders in the past; 4.Skin damage, redness, swelling, infection, etc. in the area to be stimulated; 5.Visually impaired, hearing-impaired, and difficult to communicate individuals; 6.Serious cardiovascular and cerebrovascular diseases, liver and kidney dysfunction (such as severe hepatitis, renal failure); 7.Preoperative tinnitus, sinus bradycardia, and hoarseness; 8.Presence of asthma symptoms or history of asthma; 9.Acute intestinal obstruction, intestinal perforation and other emergencies; 10.Severe respiratory system diseases (respiratory failure, severe chronic obstructive pulmonary disease); 11.Patients with serious adverse events (such as intraoperative bleeding, severe hemodynamic fluctuations); 12.Emergency operation; 13.Post operative admission to the intensive care unit; 14.Decided to withdraw from the study during the research period; 15.Second surgery within 3 days after surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative gastrointestinal dysfunction;

Secondary

MeasureTime frame
First time of getting out of bed and eating after surgery;Postoperative nausea and vomiting;First bowel movement time after surgery;postoperative delirium;Postoperative pain;First exhaust time after surgery;Additional postoperative pain relief needs;

Countries

China

Contacts

Public ContactKeyu Fan

Huzhou Center Hospital

215535169@qq.com+86 17398381638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026